Analysis of SH2D1A mutations in patients with severe Epstein-Barr virus infections, Burkitt's lymphoma, and Hodgkin's lymphoma
暂无分享,去创建一个
U. Jaeger | P. Ambros | W. Knapp | O. Haas | H. Gadner | W. Holter | B. Kagerbauer | G. Mann | O. Parolini | C. Terhorst | I. Simonitsch-Klupp | M. Morra | Walter Knapp | C. Terhorst | Ingrid Simonitsch-Klupp | Georg Mann | Helmut Gadner | Peter F. Ambros | Ulrich Jaeger | Oskar A. Haas | Massimo Morra | Wolfgang Holter
[1] O. Haas,et al. Differential methylation pattern of the X-linked lymphoproliferative (XLP) disease gene SH2D1A correlates with the cell lineage-specific transcription , 2003, Immunogenetics.
[2] O. Silander,et al. Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome. , 2001, Blood.
[3] J. Jung,et al. Abnormal T Cell Receptor Signal Transduction of CD4 Th Cells in X-Linked Lymphoproliferative Syndrome1 , 2001, The Journal of Immunology.
[4] H. Kanegane,et al. SH2D1A mutations in Japanese males with severe Epstein-Barr virus--associated illnesses. , 2001, Blood.
[5] B. van der Holt,et al. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT. , 2001, Blood.
[6] L. Notarangelo,et al. NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. , 2001, The Journal of experimental medicine.
[7] H. Kanegane,et al. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. , 2001, Blood.
[8] P. Engel,et al. Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP. , 2001, Blood.
[9] A. Sher,et al. Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[10] P. Borrow,et al. SAP controls T cell responses to virus and terminal differentiation of TH2 cells , 2001, Nature Immunology.
[11] R. Clementi,et al. Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene. , 2001, Blood.
[12] J. Schatzle,et al. Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4. , 2000, International immunology.
[13] M. Colonna,et al. Patients with X‐linked lymphoproliferative disease have a defect in 2B4 receptor‐mediated NK cell cytotoxicity , 2000, European journal of immunology.
[14] G. Klein,et al. Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. , 2000, Blood.
[15] L. Szekely,et al. SH2D1A and slam protein expression in human lymphocytes and derived cell lines , 2000 .
[16] P. Murray,et al. Hodgkin's disease and the Epstein-Barr virus , 2000, Molecular pathology : MP.
[17] H. Pabst,et al. Cutting Edge: Defective NK Cell Activation in X-Linked Lymphoproliferative Disease1 , 2000, The Journal of Immunology.
[18] L. Notarangelo,et al. X-Linked Lymphoproliferative Disease , 2000, The Journal of experimental medicine.
[19] S. Tangye,et al. 2B4-mediated activation of human natural killer cells. , 2000, Molecular immunology.
[20] K. Nichols,et al. Diagnosis of X‐linked lymphoproliferative disease by analysis of SLAM‐associated protein expression , 2000, European journal of immunology.
[21] Meindl,et al. Recurrent B‐cell non‐Hodgkin's lymphoma in two brothers with X‐linked lymphoproliferative disease without evidence for Epstein–Barr virus infection , 2000, British journal of haematology.
[22] W. Friedrich,et al. Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP). , 1999, Human molecular genetics.
[23] D. Hayoz,et al. SH2D1A mutation analysis for diagnosis of XLP in typical and atypical patients , 1999, Human Genetics.
[24] S. Tangye,et al. Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. , 1999, Journal of immunology.
[25] L. M. Shlapatska,et al. CDw150 associates with src-homology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis. , 1999, Journal of immunology.
[26] G. Konjević,et al. The difference in NK‐cell activity between patients with non‐Hodgkin's lymphomas and Hodgkin's disease , 1999, British journal of haematology.
[27] D. Allen,et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM , 1998, Nature.
[28] Jack R. Davis,et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene , 1998, Nature Genetics.
[29] M. Cazzola,et al. X-linked Wiskott-Aldrich syndrome in a girl. , 1998, The New England journal of medicine.
[30] O. Parolini,et al. High prevalence of nonsense, frame shift, and splice-site mutations in 16 patients with full-blown Wiskott-Aldrich syndrome. , 1995, Blood.
[31] Jack R. Davis,et al. X-Linked Lymphoproliferative Disease: Twenty-Five Years after the Discovery , 1995, Pediatric Research.
[32] A. Carbone,et al. Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease. , 1995, Blood.
[33] A Gloghini,et al. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease. , 1995, Cancer research.
[34] M. Pauza,et al. Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease. , 1991, American journal of medical genetics.
[35] U. Nater,et al. Epstein-Barr virus. , 1991, The Journal of family practice.
[36] D. Weisenburger,et al. Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome. , 1987, Archives of pathology & laboratory medicine.
[37] P. Engel,et al. X-linked lymphoproliferative disease: a progressive immunodeficiency. , 2001, Annual review of immunology.
[38] M. Colonna,et al. 2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism. , 2000, Human immunology.
[39] D. Purtilo,et al. X-linked lymphoproliferative syndrome provides clues to the pathogenesis of Epstein-Barr virus-induced lymphomagenesis. , 1987, Princess Takamatsu symposia.